| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 6.8e-05 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 3.4e-05 | 1 |